Abstract | AIMS: Fat deposition in the liver, which leads to nonalcoholic fatty liver disease is associated with obesity. Taurine (Tau) regulates lipid metabolism, representing a possible nutraceutical agent against obesity and its comorbidities. Here, we investigated whether Tau supplementation prevents hepatic lipid accumulation by regulation of the main hepatic genes involved in de novo lipogenesis and β-oxidation. MAIN METHODS: KEY FINDINGS: SIGNIFICANCE: Therefore, increased hepatic TG deposition in MSG-obese rats is associated with an enhanced FASN, and reduced MTP and CPT-1a genes. Tau supplementation prevented obesity and hepatic TG deposition by upregulating MTP mRNA, ameliorating hepatic lipid efflux, and consequently enhancing PPAR-α which increases lipid oxidation through ACO and CPT-1a gene expressions.
|
Authors | Maria Lúcia Bonfleur, Patrícia Cristine Borck, Rosane Aparecida Ribeiro, Luiz Carlos Caetano, Gabriela Moreira Soares, Everardo Magalhães Carneiro, Sandra Lucinei Balbo |
Journal | Life sciences
(Life Sci)
Vol. 135
Pg. 15-21
(Aug 15 2015)
ISSN: 1879-0631 [Electronic] Netherlands |
PMID | 26092479
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Elsevier Inc. All rights reserved. |
Chemical References |
|
Topics |
- Animals
- Dietary Supplements
- Fatty Acids
(metabolism)
- Gene Expression Regulation
(drug effects)
- Lipid Metabolism
(drug effects)
- Liver
(metabolism, pathology)
- Male
- Obesity
(metabolism, pathology, prevention & control)
- Rats
- Rats, Wistar
- Taurine
(pharmacology)
|